Antiepileptic Drug Mechanisms of Action

Epilepsia

Volumn 36, Issue , 1995, Pages S2-S12

  Macdonald, Robert L ^a   Kelly, Kevin M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Ethosuximide; Gabapentin; Lamotrigine; Neuropharmacology; Phenytoin; Trimethadione; Valproate; Vigabatrin

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALCIUM CHANNEL; CARBAMAZEPINE; ETHOSUXIMIDE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; SODIUM CHANNEL; VALPROIC ACID; VIGABATRIN;

ACTION POTENTIAL; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; CONFERENCE PAPER; DRUG BINDING SITE; DRUG MECHANISM; EPILEPSY; HUMAN; NONHUMAN; PRIORITY JOURNAL;

ACETIC ACIDS; ACTION POTENTIALS; ANIMAL; ANTICONVULSANTS; BARBITURATES; BENZODIAZEPINES; CALCIUM CHANNELS; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMAN; ION CHANNELS; PHENYTOIN; RATS; RECEPTORS, GABA; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NEUROTRANSMITTER; SODIUM CHANNELS; TRIAZINES; TRIMETHADIONE; VALPROIC ACID; VIGABATRIN;

EID: 0029057901     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1995.tb05996.x     Document Type: Article

References (111)

1. Experimental anticonvulsive properties of GP 47 680 and of GP 47 779, its main human metabolite: compounds related to carbamazepine.
2. Gabapentin and convulsions provoked by excitatory amino acids
3. Indications for an involvement of the GABA‐system in the mechanism of action of gabapentin.
4. Preclinical characterization of the anticonvulsant gabapentin.
5. Gabapentin in the treatment of drug‐resistant epileptic patients.
6. Pharmacokinetic effects of vigabatrin on cerebrospinal fluid amino acids in humans
7. 3H]‐propyl‐β‐carboline‐3‐carboxylate as a selective radioligand for the BZI benzodiazepine receptor subclass
8. The biochemistry and molecular biology of the dihydropydrine‐sensitive calcium channel
9. Structure and function of voltage‐sensitive ion channels
10. Gabapentin.
11. 14C]glucose into amino acids
12. An in vitro investigation of the action of lamotrigine on neuronal voltage‐activated sodium channels
13. Calcium currents in rat thalamocortical relay neurones: kinetic properties of the transient low‐threshold current
14. Specific petit mal anticonvulsants reduce calcium currents in thalamic neurons
15. Characterization of etho‐suximide reduction of low‐threshold calcium current in thalamic neurons
16. Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction
17. Cloning of the γ‐aminobu‐tyric acid (GABA) p, cDNA: a GABA receptor subunit highly expressed in the retina
18. Potential antiepileptic drugs: oxcarbazepine.
19. A receptor structure and function
20. Multiple benzodiazepine receptors‐no reason for anxiety
21. Preclinical characterization of the anticonvulsant gabapentin.
22. Postnatal development of proteins associated with different benzodiazepine receptors
23. Gabapentin.
24. Primary structure and functional expression of the ω‐contotoxin‐sensitive N‐type calcium channel from rabbit brain
25. The development of type I and type II benzodiazepine receptors in the mouse cortex and cerebellum
26. Increased gamma‐aminobutyric acid (GABA), homocarnosine and β‐alanine in cerebrospinal fluid of patients treated with gamma‐vinyl GABA (4‐amino‐hex‐5‐enoic acid)
27. 3H]gabapentin to a novel site in rat brain: autoradiographic studies
28. Molecular cloning of multiple subtypes of a novel rat brain isoform of the a, subunit of the voltage‐dependent calcium channel
29. Oxcarbazepine.
30. γ‐Vinyl GABA (4‐amino‐hex‐5‐enoic acid), a new irreversible inhibitor of GABA‐T: effects on brain GABA metabolism in mice
31. Pharmacological investigation of gamma‐aminobutyric acid (GABA) and fully developed generalized seizures in the amygdala‐kindled rat
32. Valproic acid selectively reduces the low‐threshold (T) calcium in rat nodose neurons
33. Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors
34. Comparison of gabapentin with other antiepileptic and GABAergic drugs
35. Anticonvulsant action of oxycarbazepine, hydroxycarbamazepine, and carbamazepine against metrazol‐induced motor seizures in developing rats
36. Lamotrigine and phenytoin interactions on ionic currents present in N4TG1 and GH3 clonal cells.
37. Differential effect of gamma‐vinyl GABA and valproate on GABA‐transaminase from cultured neurones and astrocytes
38. A receptor subunit messenger RNAs in the rat brain. 2. Olfactory bulb and cerebellum
39. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action
40. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex
41. Differential ontogeny of type I and type II benzodiazepine receptors
42. 4‐Amino‐hex‐5‐enoic acid, a selective catalytic inhibitor of 4‐aminobutyric‐acid aminotransferase in mammalian brain
43. Effect of microinjections of gamma‐vinyl GABA or isoniazid into substantia nigra on the development of amygdala kindling in rats
44. Gabapentin increases ami‐nooxyacetic acid‐induced GABA accumulation in several regions of rat brain
45. Antiepileptic drug actions
46. A receptor main‐conductance state of mouse spinal cord neurons in culture
47. A receptor channel of mouse spinal neurones in culture
48. Multiple actions of phenytoin on mouse spinal cord neurons in cell culture
49. Sodium valproate, but not ethosuximide, produces use‐ and voltage‐dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture
50. Carbamazepine and 10,11‐epoxycarbamazepine produce use‐ and voltage‐dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture
51. Benzodiazepines, but not beta car‐bolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture
52. Blockade of epileptic responses in photosensitive baboon Papio papio by two irreversible inhibitors of GABA‐transaminase, gamma‐acetylenic GABA (4‐amino‐hex‐5‐ynoic acid) and gamma‐vinyl GABA (4‐amino‐hex‐5‐enoic acid)
53. Anticonvulsant action in mice with sound‐induced seizures of the optical isomers of gamma vinyl GABA
54. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats
55. P‐Type calcium channels in rat central and peripheral neurons
56. Primary structure and functional expression from complementary DNA of a brain calcium channel
57. Cloned GABA receptors are maintained in a stable cell line: allosteric and channel properties
58. Lamotrigine blocks voltage‐dependent Na currents in a voltage‐dependent manner with a small use‐dependent component
59. Three types of neuronal calcium channels with different agonist sensitivity
60. The anticonvulsant action of gabapentin involves the glycine/NMDA receptor
61. The ‐γ‐aminobutyric acid/benzodiazepine/barbiturate receptor‐chloride ion channel complex of mammalian brain.
62. Aplastic anemia in a patient receiving felbamate for partial complex seizures
63. Effect of vigabatrin on GABA levels in human brain measured in vivo with ['H] NMR spectroscopy
64. A‐benzodiazepine receptors produced in transfected cells
65. A receptor a5‐subunit creates novel type II benzodiazepine receptor pharmacology
66. A receptor subunit for benzodiazepine pharmacology
67. Inhibition by GABA, baclofen, and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action?
68. Anticonvulsant therapy, megaloblastic haemopoiesis and folic acid metabolism
69. Specificity of vigabatrin for the GABAergic system in human epilepsy
70. Gabapentin actions on ligand‐ and voltage‐gated responses in cultured rodent neurons
71. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds
72. A receptor currents by opposite mechanisms.
73. Intensive monitoring and pharmacokinetic studies of gabapentin in patients with generalized spike‐wave discharges
74. Metabolic inhibitors and subcellular distribution of GABA
75. Biochemical and clinical effects of gamma‐vinyl GABA in patients with epilepsy
76. Tranier Y. Effects of elevated brain GABA concentrations on the action of bicuculline and picrotoxin in mice
77. Tranier Y, Jung MJ, Bohlen P. Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of γ‐acetylenic GABA and ‐γ‐vinyl GABA, two irreversible GABA‐T inhibitors.
78. Attempts to correlate alterations in brain GABA metabolism by GABA‐T inhibitors with their anticonvulsant effect.
79. Gabapentin decreases monoamine release without affecting acetylcholine release in the brain
80. Potential antiepileptic drugs: gabapentin.
81. GP 47779, the main human metabolite of oxcarbazepine (Trileptal), and both enantiomers have equal anticonvulsant activity
82. A receptor shows a ligand‐gated receptor super‐family
83. Stereoselective uptake of the GABA‐transaminase inhibitors gamma‐vinyl GABA and gamma‐acetylenic GABA into neurons and astrocytes
84. Phenytoin and carbamazepine: Potential‐and frequency‐dependent block of Na currents in mammalian myelinated nerve fibers
85. Anti‐seizure and anti‐epileptogenic effect of gamma‐vinyl gamma‐aminobutyric acid in amygdaloid kindling
86. A receptor subunits exist in distinct neuronal subpopulations
87. Rat brain expresses a heterogeneous family of calcium channels
88. Distinct calcium channels are generated by alternative splicing and are differentially expressed in the mammalian CNS
89. Structure and functional expression of a member of the low voltage‐activated calcium channel family
90. Primary structure of a calcium channel that is highly expressed in the rat cerebellum
91. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma
92. 3H]gabapentin binding to a novel site in rat brain: homogenate binding studies
93. + channels in a voltage‐dependent manner but gabapentin does not
94. In vitro and in vivo electrophysiology effects of the anticonvulsant gabapentin
95. Potent and ste‐reospecific anticonvulsant activity of 3‐isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin
96. A receptor system.
97. Sodium channels from human brain RN A expressed in Xenopus oocytes: basic electrophysiologic characteristics and their modifications by diphenylhy‐dantoin
98. Differential regulation of ‐γ‐aminobutyric acid receptor channels by diazepam and phenobarbital.
99. A receptor main conductance state of mouse spinal cord neurones in culture
100. Actions of benzodiazepine and β‐carboline derivatives on γ‐aminobutyric acid‐activated CI channels recorded from membrane patches of neonatal rat cortical neurons in culture
101. Multiple cellular actions of gabapentin
102. Effects of gabapentin on repetitive firing of action potentials and GABA responses of mouse central neurons in cell culture
103. Lamotrigine effects on ion channels in cultured neuronal cells
104. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate
105. Effects of chlordiazepoxide, chlorpromazine, diazepam, diphenylhydantoin, flunitrazepam and haloperidol on the voltage‐dependent sodium current of isolated mammalian brain neurons
106. Gating scheme for single GABA‐activated CI channels determined from stability plots, dwell‐time distributions, and adjacent‐interval durations
107. Structure and functional expression of a, subunits of a novel human neuronal calcium channel subtype
108. A receptor a4 subunit
109. A receptor subunit messenger RNAs in the rat brain. 1. Telencephalon, diencephalon, mesencephalon